INJECTION SITE ERYTHEMA

This adverse event was reported 124173 times

These drugs are most commonly taken by patients reporting INJECTION SITE ERYTHEMA:

# Drug Count
0 ETANERCEPT 41077
1 ADALIMUMAB 15269
2 DUPILUMAB 11789
3 METHOTREXATE SODIUM 6368
4 METHOTREXATE 6266
5 TIRZEPATIDE 5616
6 TERIPARATIDE 5069
7 INTERFERON BETA-1A 3787
8 PREDNISONE 3114
9 ERGOCALCIFEROL 3012
See all common drugs associated with INJECTION SITE ERYTHEMA

INJECTION SITE ERYTHEMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ZOPAPOGENE IMADENOVEC 20 0.5000
1 RILONACEPT 134 0.1158
2 OCRELIZUMAB AND HYALURONIDASE 53 0.1062
3 ERGOCALCIFEROL 3012 0.1013
4 PEGVALIASE-PQPZ 794 0.0932
5 ASFOTASE ALFA 881 0.0854
6 LENACAPAVIR SODIUM 43 0.0850
7 GLATIRAMER ACETATE INJECTION 391 0.0830
8 PEGINTERFERON BETA-1A 1065 0.0813
9 OLEZARSEN SODIUM 77 0.0813
See all drugs enriched for association with INJECTION SITE ERYTHEMA

INJECTION SITE ERYTHEMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 198 0.2878
1 Adrenocorticotropic Hormone [EPC] 132 0.1475
2 PCSK9 Inhibitor [EPC] 2686 0.1043
3 Provitamin D2 Compound [EPC] 3012 0.1012
4 Endoglycosidase [EPC] 179 0.0966
5 Phenylalanine Metabolizing Enzyme [EPC] 794 0.0932
6 Tissue-nonspecific Alkaline Phosphatase [EPC] 881 0.0854
7 Melanocortin 4 Receptor Agonist [EPC] 22 0.0772
8 Interleukin-17A Antagonist [EPC] 2683 0.0720
9 Skin Test Antigen [EPC] 91 0.0483
See all drug classes enriched for association with INJECTION SITE ERYTHEMA